DCM Shriram Q2 FY27 Call Set for October 28, 2026
Ask Iris
Board meeting scheduled for October 26
DCM Shriram Ltd has informed the exchanges that its Board of Directors will meet on Monday, October 26, 2026. The board is scheduled to consider and approve the company’s unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting agenda also includes consideration of an interim dividend, if any, for FY 2026-27. The disclosure was made under Regulation 29 of the SEBI Listing Regulations. The September quarter is the second quarter of the company’s financial year and covers the period from July 1 to September 30, 2026.
Earnings conference call on October 28
The company has scheduled an earnings conference call for Wednesday, October 28, 2026, at 4:00 PM IST. Management is expected to discuss the Q2 FY27 financial performance and the first-half numbers after the results are considered by the board. Analysts and investors have been invited to participate through dial-in and pre-registration arrangements communicated by the company. The call provides a forum for management commentary on quarterly operations, reported financial metrics and the outlook discussed alongside the results. The scheduled call date does not itself disclose the Q2 financial outcome.
Interim dividend remains subject to board approval
An interim dividend is included in the October 26 board agenda, but no dividend has been declared through the intimation. Any decision on a payout, including the amount and relevant record-date details, would depend on the board’s approval. Investors should distinguish between an item proposed for consideration and a final corporate action. The company’s subsequent exchange filing will provide the formal details if an interim dividend is approved. Until then, there is no confirmed dividend figure in the available disclosure.
Q1 FY27 provides the latest reported reference point
The provided quarterly snapshot places DCM Shriram’s consolidated Q1 FY27 net sales at ₹3,564.24 crore. The same data set states that revenue was up 11.61% sequentially and 9.27% from a year earlier. It also reports gross profit of ₹208 crore, down 3.27% quarter-on-quarter and up 8.45% year-on-year. Reported net profit in the snapshot was ₹692 crore, with a quarter-on-quarter increase of 86.67%. These figures are the latest reported indicators supplied for DCM Shriram ahead of the September-quarter announcement.
September-quarter comparison base
The information available for the year-earlier September quarter indicates consolidated revenue of ₹3,272 crore and net profit of ₹159 crore for Q2 FY26. Other supplied summaries describe Q2 FY26 revenue as ₹3,432.43 crore, alongside EBITDA of ₹407.93 crore and net profit of ₹158.72 crore. Since the provided material contains differing revenue presentations, investors should rely on the company’s filed financial statements and notes to accounts for the exact comparable base. The reported net-profit figures across these summaries are broadly similar at about ₹159 crore. The forthcoming Q2 FY27 filing should clarify the company’s selected reporting basis and comparative disclosures.
Key reported figures at a glance
What investors will monitor in the results
The Q2 FY27 release will provide the first official financial update for DCM Shriram after its June-quarter performance. Revenue progression against both the Q1 FY27 level and the year-earlier September quarter will be closely tracked. Investors will also assess operating profitability, finance costs, tax items and the movement in net profit. Segment-level commentary, if included in the filing or conference call, may offer context on operational trends across the group’s businesses. Any interim dividend decision will be another item of interest for shareholders.
Regulatory timeline for the September quarter
Listed companies are required to disclose quarterly financial results within the applicable timeline under the listing framework. For the September 2026 quarter, the provided material notes November 14, 2026, as the outer deadline for publication. DCM Shriram’s scheduled October 26 board meeting places its results consideration before that deadline. The October 28 investor call follows shortly after the board meeting. This sequence gives market participants a defined timetable for the result announcement and management interaction.
Separate companies should not be confused
The supplied material also contains financial information relating to DCM Shriram Industries Ltd and DCM Shriram Fine Chemicals Ltd. These are separate entities and their revenue, profit and result-date references should not be treated as DCM Shriram Ltd’s consolidated performance. For example, DCM Shriram Industries reported Q1 FY27 revenue of ₹293.63 crore and net profit of ₹1.55 crore in the supplied data. DCM Shriram Fine Chemicals reported Q1 FY27 revenue of ₹90.78 crore and net profit of ₹2.59 crore. Such figures are not comparable with DCM Shriram Ltd’s consolidated results.
Next disclosures to watch
DCM Shriram’s October 26 board meeting is the next confirmed event for the September-quarter results. The company is then scheduled to hold its Q2 FY27 earnings call at 4:00 PM IST on October 28. Investors will need to wait for the formal results filing for confirmed revenue, profitability, segment performance and any interim dividend decision. The filing and the management call will provide the relevant basis for assessing the quarter against the company’s earlier reported numbers.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker